Overview
Margot Tertrais practices practicing medicine in Toulouse, France.
Her clinical expertise encompasses Retinopathy Pigmentary Mental Retardation and Usher Syndrome.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Margot Tertrais
Is Margot Tertrais a top-rated expert for Retinopathy Pigmentary Mental Retardation?
MediFind is an objective health platform that identifies experts based on real-world data. Margot Tertrais is classified as an Experienced expert for Retinopathy Pigmentary Mental Retardation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Margot Tertrais participate in research or clinical trials?
Yes. Margot Tertrais has published 8 articles and abstracts on conditions like Retinopathy Pigmentary Mental Retardation. You can view a list of Margot Tertrais's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Retinopathy Pigmentary Mental RetardationMs. Tertrais isExperienced. Learn about Retinopathy Pigmentary Mental Retardation.
- Usher SyndromeMs. Tertrais isExperienced. Learn about Usher Syndrome.